Upregulation of miR-1179 in breast cancer serves as a tumour suppressor and is also involved in suppression of Notch signaling pathway in breast cancer.20 The non-binding of hsa-miR-1179 with BRCA1 mRNA signifies loss of an anti-oncogenic regulator and chance of oncogenesis. The gene discussed is BRCA1; the disease is breast cancer.